✦ LIBER ✦

Duration of evidence-based medical therapy and the hazard for atherothrombotic events following percutaneous coronary intervention

✍ Scribed by Herbert D. Aronow; Robert L. Strawderman; Mauro Moscucci; Mark E. Cowen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Percutaneous coronary interventions for

✍ R. Jaumdally; G. Y. H. Lip; C. Varma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Application of Evidence-Based Medical Th

✍ Wissam A. Jaber; Ryan J. Lennon; Verghese Mathew; David R. Holmes Jr; Amir Lerma 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 116 KB

The Risk of Adverse Cardiac and Bleeding

✍ Singla, Sandeep; Sachdeva, Rajesh; Uretsky, Barry F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 889 KB

Use of Evidence-Based Medical Therapy in

✍ Mark J Eisenberg; MD; MPH; Robert M Califf; MD; Eric A Cohen; MD; Allan G Adelma 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Association of Clopidogrel Pretreatment

✍ Bellemain-Appaix, Anne; O’Connor, Stephen A.; Silvain, Johanne; Cucherat, Michel 📂 Article 📅 2012 🏛 American Medical Association 🌐 English ⚖ 444 KB

Intensive oral antiplatelet therapy for

✍ Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Ivan Horvath; Matyas Kelt 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 247 KB